LEVAMISOLE AND INOSIPLEX: ANTIVIRAL AGENTS WITH IMMUNOPOTENTIATING ACTION *
1977; Wiley; Volume: 284; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1977.tb21945.x
ISSN1749-6632
AutoresJohn W. Hadden, Carlos López, Richard J. O’Reilly, Elba M. Hadden,
Tópico(s)IL-33, ST2, and ILC Pathways
ResumoAnnals of the New York Academy of SciencesVolume 284, Issue 1 p. 139-152 LEVAMISOLE AND INOSIPLEX: ANTIVIRAL AGENTS WITH IMMUNOPOTENTIATING ACTION * John W Hadden, John W Hadden Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021 Recipient of an Established Investigatorship of the American Heart AssociationSearch for more papers by this authorCarlos Lopez, Carlos Lopez Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this authorRichard J O'Reilly, Richard J O'Reilly Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this authorElba M Hadden, Elba M Hadden Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this author John W Hadden, John W Hadden Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021 Recipient of an Established Investigatorship of the American Heart AssociationSearch for more papers by this authorCarlos Lopez, Carlos Lopez Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this authorRichard J O'Reilly, Richard J O'Reilly Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this authorElba M Hadden, Elba M Hadden Laboratories of Immunopharmacology, Herpes, and Microbial Immunology Memorial Sloan-Kettering Cancer Center New York, New York 10021Search for more papers by this author First published: May 1977 https://doi.org/10.1111/j.1749-6632.1977.tb21945.xCitations: 61 * Supported by the National Institutes of Health (NCI-08748-08), The Sloan-Kettering Institute, and the American Heart Association. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Renoux, G. & M. Renoux. 1972. J. Immunol. 109: 761–765. CASPubMedWeb of Science®Google Scholar 2 Renoux, G. & M. Renoux. 1974. J. Immunol. 113: 779–790. CASPubMedWeb of Science®Google Scholar 3 Symoens, J. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia II. M. A. Chirigos, Ed. U.S. Government Printing Office. Washington , D.C. In press. Google Scholar 4 Spitler, L. E., R. Glogau, D. Nelms, K. Basch, J. Olson, S. Silverman & L. Engleman. 1976. Ibid.. Google Scholar 5 Fischer, G. W., M. H. Crumrine, M. W. Balk, S. P. Chang & Y. Hokama. 1976. Ibid.. Google Scholar 6 O'Reilly, R., A. Chibbaro, R. Wilmot & C. Lopez. 1976. Ann. N.Y. Acad. Sci. This volume. Google Scholar 7 Kint, A. & L. Verlinden. 1974. N. Engl. J. Med. 291: 308. 10.1056/NEJM197408082910614 CASPubMedWeb of Science®Google Scholar 8 Wickett, W. L., Jr.. Personal communication. Google Scholar 9 Waldman, R. H. 1976. Ann. N.Y. Acad. Sci. This volume. Google Scholar 10 Glasky, A. J., E. H. Pfadenhauer, R. Settineri & T. Ginsberg. 1975. In Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency, A Molecular Defect. H. J. Meuwissen, Ed.: 157–172. Academic Press. San Francisco , Calif . Google Scholar 11 Longely, S., R. L. Dunning & R. H. Waldman. 1973. Antimicrob. Agents Chemother. 3: 506–509. 10.1128/AAC.3.4.506 PubMedWeb of Science®Google Scholar 12 Pachuta, D. M., T. Yasushi, R. B. Hornick, A. R. Schwartz & S. Tominaga. 1974. Antimicrob. Agents & Chemother. 5: 403–408. 10.1128/AAC.5.4.403 CASPubMedWeb of Science®Google Scholar 13 Gordon, P., B. Ronsen & E. R. Brown. 1974. Antimicrob. Agents Chemother. 5: 153–160. 10.1128/AAC.5.2.153 CASPubMedWeb of Science®Google Scholar 14 Hadden, J. W., E. M. Hadden & R. G. Coffey. 1976. Infect. Immun. 13: 382–387. CASPubMedWeb of Science®Google Scholar 15 Wheelock, E. F. & S. T. Toy. 1973. Advan. Immunol. 16: 123–184. 10.1016/S0065-2776(08)60297-7 CASPubMedGoogle Scholar 16 Fischer, G. W., J. E. Podgore & J. W. Bass. 1975. Lancet i: 1137. 10.1016/S0140-6736(75)92523-4 CASGoogle Scholar 17 Rojas, A. & A. J. Olivari. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia II. M.A. Chirigos, Ed. U.S. Government Printing Office, Washington , D.C. In press. Google Scholar 18 Gordon, B. L. & J. P. Keenan. 1975. Ann. Allerg. 35: 343–346. PubMedWeb of Science®Google Scholar 19 Renoux, G. Personal communication. Google Scholar 20 Schuermans, Y. 1975. Lancet i: 111. 10.1016/S0140-6736(75)91127-7 Google Scholar 21 Chang, T. & L. Weinstein. 1973. Amer. J. Med. Sci. 265: 143–146. 10.1097/00000441-197302000-00005 CASPubMedWeb of Science®Google Scholar 22 Muldoon, R. L., L. Mezny & G. Jackson. 1972. Antimicrob. Agents Chemother. 2: 224–228. 10.1128/AAC.2.3.224 CASPubMedWeb of Science®Google Scholar 23 Gordon, P. & E. R. Brown. 1972. Can. J. Microbiol. 18: 1463–1470. 10.1139/m72-224 CASPubMedWeb of Science®Google Scholar 24 Lopez, C. 1975. Nature 258: 152–153. 10.1038/258152a0 PubMedWeb of Science®Google Scholar 25 Renoux, G. & M. Renoux, M. N. Teller, S. McMahon & J. M. Guillaumin. 1976. Clin. Exp. Immunol. 25: 288–296. CASPubMedWeb of Science®Google Scholar 26 Faanes, R. B., Dillon, P. & Y. S. Choi. 1976. Clin. Exp. Immunol. In press. Google Scholar 27 Chirigos, M. A., J. W. Pearson & J. Prior. 1973. Cancer Res. 33: 2615–2618. CASPubMedWeb of Science®Google Scholar 28 Renoux, G., M. Renoux & D. Aycardi. 1976. Personal communication. Google Scholar 29 Renoux, G & M. Renoux. 1971. C. R. Acad. Sci. (Paris) 274D: 349–350. Google Scholar 30 Chirigos, M. S., S. J. Mohr & S. D. Chaparas. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia I. M. A. Chirigos, Ed. Fogarty. Int. Cancer Proceedings No. 28. U.S. Government Printing Office, Washington , D.C. In press. Google Scholar 31 Sunshine, G., E. Corrales-Lopez, E. Hadden, R. Coffey, H. Wanebo, J. W. Hadden & A. Rojas. 1976. Ibid. Google Scholar 32 Brugmans, J., V. Schuermans, W. De Cock, D. Thienpont, P. Janssen, H. Verhafgen, L. V. Nimmen, A. C. Louwagie & E. Stevens. 1973. Life Sci. 13: 1499–1504. 10.1016/0024-3205(73)90137-9 CASPubMedWeb of Science®Google Scholar 33 Tripodi, D., L. C. Parks & J. N. Brugmans. 1973. N. Engl. J. Med. 289: 354–357. 10.1056/NEJM197308162890707 CASPubMedWeb of Science®Google Scholar 34 Bradshaw, L. J. 1976. Ann. N.Y. Acad. Sci. This volume. Google Scholar 35 Woods, W. A., M. J. Fliegelman & M. A. Chirigos. 1975. Proc. Soc. Exp. Biol. Med. 148: 1048–1050. 10.3181/00379727-148-38686 CASPubMedWeb of Science®Google Scholar 36 Hadden, J. W., R. G. Coffey, E. M. Hadden, E. Corrales-Lopez & G. H. Sunshine. 1975. Cell. Immunol. 20: 98–103. 10.1016/0008-8749(75)90088-X CASPubMedWeb of Science®Google Scholar 37 Renoux, G. & M. Renoux. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia I. M. A. Chirigos, Ed. Fogarty Int. Center Proceedings, No. 28. U.S. Government Printing Office, Washington , D.C. In press. Google Scholar 38 Lima, A. O., M. Q. Javierre, W. D. DaSilva & D. S. Camara. 1974. Experientia 30: 945–946. 10.1007/BF01938377 CASPubMedWeb of Science®Google Scholar 39 Lichtenfeld, J. L., M. R. Desner, P. H. Wiernik, S. Moore & M. R. Mardinay, Jr.. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia I. M. A. Chirigos, Ed. Fogarty Int. Center Proceedings, No. 28. U.S. Government Printing Office, Washington , D.C. In press. Google Scholar 40 Pabst, H. F. & J. Crawford. 1975. Clin. Exp. Immunol. 21: 468–473. CASPubMedWeb of Science®Google Scholar 41 Copeland, D., T. Stewart & J. Harris. 1974. Cancer Chemother. Rep. 58: 167–170. CASPubMedWeb of Science®Google Scholar 42 Biniaminov, M. & B. Ramot. 1975. Lancet i: 464. 10.1016/S0140-6736(75)91543-3 Google Scholar 43 Wright, D. G., C. H. Kirkpatrick & J. I. Gallin. 1976. In Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasia II. M. A. Chirigos, Ed. U.S. Government Printing Office, Washington , D.C. In press. Google Scholar 44 Ginsberg, T. & A. Glasky. 1976. Ann. N.Y. Acad. Sci. This volume. Google Scholar 45 Van Belle, H. 1972. Biochim. Biophys. Acta 289: 158–168. 10.1016/0005-2744(72)90118-0 PubMedWeb of Science®Google Scholar 46 Goldberg, N. D., W. D. Lust, R. F. O'Dea, S. Wei & A. G. O'Toole. 1970. In Advances in Biochemical Psychopharmacology. P. Greengard & E. Costa, Eds. Vol. 3: 67–87. Raven Press. New York , N.Y. Google Scholar 47 Hadden, J. W. 1975. Ann. N.Y. Acad. Sci. 256: 352–364. 10.1111/j.1749-6632.1975.tb36062.x CASPubMedWeb of Science®Google Scholar 48 Renoux, G. & M. Renoux, 1974. C. R. Acad. Sci. (Paris) 278: 1139–1141. CASPubMedWeb of Science®Google Scholar 49 Ronsen, B. & P. Gordon. 1976. Biochem. Pharm. 25: 707–715. 10.1016/0006-2952(76)90248-3 CASPubMedWeb of Science®Google Scholar 50 Hoffman, M. K., O. Weiss, S. Koenig, J. A. Hirst & H. F. Oettgen. 1975. J. Immunol. 114: 738–740. PubMedWeb of Science®Google Scholar Citing Literature Volume284, Issue1Third Conference on Antiviral SubstancesMay 1977Pages 139-152 ReferencesRelatedInformation
Referência(s)